Latin America News Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America News Network.

Press releases published on October 7, 2026

Optogenetic therapy is safe and allows blind people to detect objects
BTW.Media Directory: Connecting the Internet Industry
Lifecore Biomedical to Participate at Upcoming Industry Conferences
Moda Por Una Causa Celebrates Sixth Edition with International Runway Show
Admission to Trading and PDMR Transaction
Xcalacoco: el norte de Playa del Carmen pasa de corredor turístico a nueva comunidad residencial
Gate Launches Gate Money, a New Financial Services Gateway Connecting Assets, Funds, and Payments
NeOnc among Names with 2026 Breakthroughs that Offer New Hope in the Fight Against Cancer
Golar LNG acquires conversion vessel for 4th FLNG
AIM ImmunoTech’s Strategy to Address Immune Resistance in Pancreatic Cancer Featured in BioTuesdays
Avaí Bio and Austrianova Hold First Joint Steering Committee Meeting with Ospedale San Raffaele for Diabetes Cell Therapy Program
Clearmind Advances Dialogue with U.S. Federal Government on Psychedelic Therapies, Submitting Recommendations to FDA
RenovoRx Advances TAMP™ into Borderline Resectable Pancreatic Cancer with First Patient Enrolled in Investigator-Initiated PRISM-TAMP Trial
Achieve Life Sciences Appoints Kaitlyn Tuson as Senior Vice President, Marketing and Communications
Theialife Announces Positive Type C Meeting with FDA for ND10 in Progressive Myopia
AMLM Announces Conversion of Worldwide Diversified Holdings, Inc. Note into Common Shares, Strengthening Balance Sheet and Expanding Shareholder Base
Skyharbour Commences Drilling at the Getty East Uranium Joint Venture with Partner Denison Mines at the Russell Lake Project Area
Kyverna Therapeutics to Present Positive Data in Stiff Person Syndrome and Progressive Multiple Sclerosis at MSToronto2026
Atsena Presents Positive Preliminary Safety and Efficacy Results from Parts A and B of the Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis
Cerevance Announces Positive Phase 3 ARISE Results: Once-daily Oral Solengepras Meets Primary Endpoint and Demonstrates Motor and Non-motor Benefits in Parkinson's Disease

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Latin America News Network

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.